Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina.
University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology, Birmingham, Alabama.
AIDS Educ Prev. 2021 Apr;33(2):158-168. doi: 10.1521/aeap.2021.33.2.158.
Cigarette smoking remains disproportionately prevalent and is increasingly a cause of death and disability among people with HIV (PWH). Many PWH are interested in quitting, but interest in and uptake of first-line smoking cessation pharmacotherapies are varied in this population. To provide current data regarding experiences with and perceptions of smoking cessation and cessation aids among PWH living in Durham, North Carolina, the authors conducted five focus group interviews (total = 24; 96% African American) using semistructured interviews. Interviews were recorded, transcribed, coded, and thematically analyzed. Major themes included ambivalence and/or lack of interest in cessation; presence of cessation barriers; perceived perceptions of ineffectiveness of cessation aids; perceived medication side effects; and conflation of the harms resulting from use of tobacco products and nicotine replacement therapy. Innovative and effective interventions must account for the aforementioned multiple barriers to cessation as well as prior experiences with and misperceptions regarding cessation aids.
吸烟在艾滋病毒感染者（PWH）中仍然不成比例地普遍存在，并且越来越成为死亡和残疾的原因。许多 PWH 有戒烟的意愿，但在这一人群中，对一线戒烟药物治疗的兴趣和采用情况各不相同。为了提供北卡罗来纳州达勒姆 PWH 对戒烟和戒烟辅助工具的经验和看法的最新数据，作者使用半结构化访谈进行了五次焦点小组访谈（共 24 人；96%为非裔美国人）。访谈进行了录音、转录、编码和主题分析。主要主题包括对戒烟的矛盾心理和/或缺乏兴趣；存在戒烟障碍；对戒烟辅助工具无效的看法；对药物副作用的看法；以及将使用烟草制品和尼古丁替代疗法所带来的危害混为一谈。创新和有效的干预措施必须考虑到上述多种戒烟障碍，以及之前对戒烟辅助工具的经验和误解。
